RSS-Feed abonnieren
DOI: 10.1055/s-2007-966649
© Georg Thieme Verlag KG Stuttgart · New York
Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett’s esophagus
Publikationsverlauf
submitted 19 January 2007
accepted after revision 31 May 2007
Publikationsdatum:
05. Juli 2007 (online)
Background and study aims: Computed virtual chromoendoscopy (CVC) is a new imaging technique that enhances mucosal surface contrast and highlights the vascular pattern without the need for dye-spraying as in conventional chromoendoscopy. The aim of this prospective randomized pilot study with a crossover design was to compare CVC with conventional chromoendoscopy with acetic acid (CAA) for the detection of high grade intraepithelial neoplasia (HGIN) or early cancer in patients with Barrett’s esophagus.
Patients and methods:57 patients with Barrett’s esophagus (mean length 3.8 cm) and a history of HGIN/early cancer or suspected HGIN/early cancer were randomly allocated to undergo either CAA or CVC. All patients were re-examined with the alternative procedure at 4 - 6 weeks after the initial endoscopy. The two procedures were performed by five endoscopists, who were blinded to the findings of the other examination. At each examination, targeted biopsies were taken from all detected lesions, followed by random four-quadrant biopsies.
Results: In 24/57 patients, 30 lesions with HGIN/early cancer were detected. The sensitivity of targeted biopsies for HGIN/early cancer on a ‘per lesion’ basis was 87 % (26/30) for both CAA and CVC. The positive predictive value was 39 % (26/66) for CAA and 37 % (26/70) for CVC. In the ‘per patient’ analysis, sensitivity was 83 % (20/24) and 92 % (22/24) for CAA and CVC, respectively (P = 0.617). Stepwise random four-quadrant biopsies identified only one patient with HGIN/early cancer that was missed by both, CAA and CVC.
Conclusions: Computed virtual chromoendoscopy is a helpful adjunct for surveillance of Barrett’s esophagus and appears to be as accurate as conventional chromoendoscopy in the detection of HGIN/early cancer.
References
- 1 Haggitt R C, Tryzelaar J, Ellis F H. et al . Adenocarcinoma complicating columnar epithelium-lined (Barrett’s) esophagus. Am J Clin Pathol. 1978; 70 1-5
- 2 Corley D A, Levin T R, Habel L A. et al . Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterology. 2002; 122 633-640
- 3 Sampliner R E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett‘s esophagus. Am J Gastroenterol. 2002; 97 1888-1895
- 4 Levine D S, Haggitt R C, Blount P L. et al . An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology. 1993; 104 40-50
- 5 Ell C, May A, Gossner L. et al . Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett’s esophagus. Gastroenterology. 2000; 118 670-677
- 6 Ell C, May A, Pech O. et al . Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc. 2007; 65 3-10
- 7 Peters F P, Kara M A, Rosmolen W D. et al . Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc. 2005; 61 506-514
- 8 Guelrud M, Herrera I, Essenfeld H. et al . Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett‘s esophagus. Gastrointest Endosc. 2001; 53 559- 565
- 9 Sharma P, Weston A P, Topalovski M. et al . Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus. Gut. 2003; 52 24-27
- 10 Gossner L, Pech O, May A. et al . Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett’s esophagus. Dig Liver Dis. 2006; 38 724-729
- 11 Canto M I, Yoshida T, Gossner L. Chromoendoscopy of intestinal metaplasia in Barrett’s esophagus. Endoscopy. 2002; 34 330-336
- 12 Hoffman A, Kiesslich R, Bender A. et al . Acetic acid-guided biopsies after magnifying endoscopy compared with random biopsies in the detection of Barrett’s esophagus: a prospective randomized trial with crossover design. Gastrointest Endosc. 2006; 64 1-8
- 13 Guelrud M, Ehrlich E E. Endoscopic classification of Barrett’s esophagus. Gastrointest Endosc. 2004; 59 58-65
- 14 Rey J F, Inoue H, Guelrud M. Magnification endoscopy with acetic acid for Barrett’s esophagus. Endoscopy. 2005; 37 583-586
- 15 Lambert R, Rey J F, Sankaranarayanan R. Magnification and chromoscopy with the acetic acid test. Endoscopy. 2003; 35 437-445
- 16 Yagi K, Nakamura A, Sekine A. Comparison between magnifying endoscopy and histological, culture and urease test findings from the gastric mucosa of the corpus. Endoscopy. 2002; 5 375-376
- 17 Gono K, Yamazaki K, Doguchi N. et al . Endoscopic observation of tissue by narrow-band illumination. Opt Rev. 2003; 10 1-5
- 18 Machida H, Sano Y, Hamamoto Y. et al . Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study. Endoscopy. 2004; 36 1094-1098
- 19 Kara M A, Peters F P, Rosmolen W D. et al . High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a prospective randomized crossover study. Endoscopy. 2005; 37 929-936
- 20 Pohl J, May A, Rabenstein T. et al . Computed virtual chromoendoscopy (CVC): a new tool for enhancing tissue surface structures. Endoscopy. 2007; 39 80-83
- 21 Schlemper R J, Hirata I, Dixon M F. The macroscopic classification of early neoplasia of the digestive tract. Endoscopy. 2002; 34 163-168
- 22 Endo T, Awakawa T, Takahashi H. et al . Classification of Barrett’s epithelium by magnifying endoscopy. Gastrointest Endosc. 2002; 55 641-647
- 23 Hamamoto Y, Endo T, Nosho . et al . Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett’s esophagus. J Gastroenterol. 2004; 39 14-20
- 24 Yoshida T, Inoue H, Usui S. et al . Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc. 2004; 59 288-295
J. Pohl, MD, PhD
Department of Internal Medicine II
Dr. Horst Schmidt Klinik
Ludwig-Erhard-Str. 100
Wiesbaden
Germany
Fax: +49-611-432418
eMail: pohljuergen@web.de